Publication:
Pyrrolidine dithiocarbamate treatment prevents ethylene glycol-induced urolithiasis through inhibition of NF-kappaB and p38-MAPK signaling pathways in rat kidney.

Simple item page
dc.contributor.authorIlbey, YUSUF ÖZLEM
dc.contributor.authorOzbek, Emin
dc.contributor.authorSimşek, Abdulmuttalip
dc.contributor.authorCekmen, Mustafa
dc.contributor.authorSomay, Adnan
dc.contributor.authorTasci, Ali Ihsan
dc.contributor.institutionauthorİLBEY, YUSUF ÖZLEM
dc.date.accessioned2022-01-27T20:59:52Z
dc.date.available2022-01-27T20:59:52Z
dc.date.issued2010-06-01T00:00:00Z
dc.identifier.citationIlbey Y. Ö. , Ozbek E., Simşek A., Cekmen M., Somay A., Tasci A. I. , -Pyrrolidine dithiocarbamate treatment prevents ethylene glycol-induced urolithiasis through inhibition of NF-kappaB and p38-MAPK signaling pathways in rat kidney.-, Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica, cilt.82, sa.2, ss.87-94, 2010
dc.identifier.pubmed20812531
dc.identifier.scopus77955788901
dc.identifier.urihttp://hdl.handle.net/20.500.12645/30317
dc.titlePyrrolidine dithiocarbamate treatment prevents ethylene glycol-induced urolithiasis through inhibition of NF-kappaB and p38-MAPK signaling pathways in rat kidney.
dc.typeArticle
dspace.entity.typePublication
local.avesis.id65181d00-fb36-4650-ba95-99bd84c235a6
local.indexed.atPubMed
local.indexed.atScopus
local.publication.isinternational1
relation.isAuthorOfPublicatione166fdca-de94-48b0-a771-14053e70c6ca
relation.isAuthorOfPublication.latestForDiscoverye166fdca-de94-48b0-a771-14053e70c6ca

Files

Collections

Yayınlar - Eserler